# Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis

> **NCT02566655** · PHASE1 · COMPLETED · sponsor: **Red de Terapia Celular** · enrollment: 10 (estimated)

## Conditions studied

- Osteoporosis
- Spinal Fractures

## Interventions

- **BIOLOGICAL:** Fucosylated MSC for Osteoporosis

## Key facts

- **NCT ID:** NCT02566655
- **Lead sponsor:** Red de Terapia Celular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-12
- **Final completion:** 2018-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02566655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02566655, "Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02566655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*